Clinical Trials on Adult Onset Rheumatoid Arthritis in Russian Federation

Total 270 results

R-Pharm International, LLC
Data Management 365; Federal State Budgetary Educational Institution for Higher... and other collaborators

Withdrawn

Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)

Adult-Onset Still's Disease | AOSD

Russian Federation
Institute of Biomedical Chemistry, Russia
Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy

Completed

Predicting the Response of Patients With Rheumatoid Arthritis to Treatment With Genetically Engineered Biological Drugs and Janus (JAK) Kinase Inhibitors

Rheumatoid Arthritis

Russian Federation
Biocad

Completed

Study of the Efficacy and Safety of BCD-089 in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis (SOLAR)

Rheumatoid Arthritis

Russian Federation
Biointegrator LLC

Terminated

Safety, Tolerability, PK and PD of Biosimilar Drug Ritumax® Compared to Original Drug MabThera®

Rheumatoid Arthritis

Russian Federation
Regeneron Pharmaceuticals
Sanofi

Completed

A Safety and Tolerability Study of REGN88(SAR153191) in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Russian Federation
Abbott

Completed

A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Russian Federation
Theramab LLC

Completed

Safety, Tolerability, Pharmacodynamics and Efficacy Study of TAB08 in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Russian Federation
Biocad

Active, not recruiting

A Two-Stage Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Various Doses of Levilimab When Administered Intravenously and Subcutaneously to Healthy Subjects and Subjects With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Russian Federation
GlaxoSmithKline

Completed

Repeat Dose Subcutaneous Rhumatoid Arthritis Efficacy Study

Arthritis, Rheumatoid

Russian Federation
Novo Nordisk A/S

Completed

Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid Arthritis

Inflammation | Rheumatoid Arthritis

Russian Federation, Germany
Russian Academy of Medical Sciences

Completed

Autologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis (TolDCfoRA)

Immune System Diseases | Autoimmune Diseases | Arthritis | Arthritis, Rheumatoid | Musculoskeletal Diseases | Rheumatic Diseases | Connective Tissue Diseases | Joint Disease

Russian Federation
Novartis

Completed

Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis

Rheumatoid Arthritis

Russian Federation, Spain, Turkey, Switzerland
Biocad

Completed

The BCD-089 (aIL6R) in Patients With Active Rheumatoid Arthritis (AURORA)

Seropositive RA

Russian Federation, Belarus
Janssen Research & Development, LLC

Completed

Efficacy of NNC0142-0002 in Subjects With Rheumatoid Arthritis (RA)

Inflammation | Rheumatoid Arthritis

Germany, Russian Federation, Ukraine
Medical University of Vienna

Completed

A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action

Rheumatoid Arthritis

Austria, Czechia, Russian Federation, Switzerland
Hoffmann-La Roche

Completed

An Extension Study of WA19926 of the Long-Term Safety of Tocilizumab (RoActemra/Actemra) in Patients With Early Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis

Russian Federation
Novo Nordisk A/S

Completed

A Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0215-0384 Administered to Subjects With Moderate to Severe Rheumatoid Arthritis

Inflammation | Rheumatoid Arthritis

Germany, Russian Federation, Poland, Hungary
Ionis Pharmaceuticals, Inc.

Completed

Safety, Tolerability, and Pharmacodynamic Study of ISIS CRP Rx in Rheumatoid Arthritis

Rheumatoid Arthritis

Canada, Russian Federation
Mabscale, LLC

Active, not recruiting

Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Russian Federation
Biogen

Completed

BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

United States, Russian Federation
Swiss Medica XXI Century S.A.

Unknown

The Evaluation of Safety and Effectiveness of Intraarticular Administration of Autologous Stromal-Vascular Fraction of Adipose Tissue Cells for Treatment of Knee Joint Arthrosis

Knee Osteoarthritis

Russian Federation, Serbia
Sanofi

Completed

Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis (ACCORD-RA)

Rheumatoid Arthritis

Romania, Russian Federation, Ukraine, Bulgaria, Slovakia, Croatia, Czechia
Biogen

Completed

Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) Participants (RESPOND)

Rheumatoid Arthritis

Argentina, Mexico, Romania, Brazil, Hungary, Poland, Russian Federation, United Kingdom
Negovsky Reanimatology Research Institute

Recruiting

The Impact of Single-shot Adductor Canal Block Versus Continuous Femoral Nerve Block on Rehabilitation After Total Knee Replacement

Osteo Arthritis Knee | Gonarthrosis

Russian Federation
Hoffmann-La Roche

Completed

A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.

Rheumatoid Arthritis

Russian Federation
Biogen

Terminated

104RA204 Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Participants (RESPOND-EXT)

Rheumatoid Arthritis

Argentina, Brazil, Hungary, Mexico, Poland, Romania, Russian Federation, United Kingdom
Galapagos NV

Completed

Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients

Rheumatoid Arthritis

Hungary, Moldova, Republic of, Russian Federation, Ukraine
GlaxoSmithKline

Completed

A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid Arthritis

Arthritis, Rheumatoid

Russian Federation, Spain, Romania
UCB Celltech
PRA Health Sciences

Completed

Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

Czechia, Hungary, Moldova, Republic of, Poland, Russian Federation, Slovakia, United Kingdom
Russian Academy of Medical Sciences

Completed

Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment

Osteoarthritis | Joint Disease | Arthritis, Degenerative | Osteoarthrosis | Osteoarthrosis Deformans | Osteoarthritis,Knee

Russian Federation
GlaxoSmithKline

Terminated

Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis

Arthritis, Rheumatoid

Russian Federation, Spain, United Kingdom
Samara State Medical University
City Clinical Hospital No.1 named after N.I. Pirogov

Recruiting

New Method of Surgical Treatment of Patients With Osteoarthritis of the 1st Metatarsophalangeal Joint

Osteoarthritis

Russian Federation
Galapagos NV

Completed

GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis

Rheumatoid Arthritis

Belgium, Netherlands, Poland, Russian Federation, Ukraine
NPO Petrovax

Completed

A Study to Assess Efficacy of Supporting Properties and Safety of ARTNEO in Patients With Knee Osteoarthritis

Osteoarthritis | Osteoarthritis, Knee | Osteo Arthritis Knee

Russian Federation
Takeda

Terminated

Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to Methotrexate (TELLUS)

Rheumatoid Arthritis

Spain, Estonia, Russian Federation, Czechia, United Kingdom
Central Clinical Hospital w/Outpatient Health Center...
I.M. Sechenov First Moscow State Medical University

Completed

Effectiveness and Safety of Autologous ADRC for Treatment of Degenerative Damage of Knee Articular Cartilage

Knee Joint Osteoarthritis

Russian Federation
I.M. Sechenov First Moscow State Medical University

Recruiting

Optimization of Total Knee Arthroplasty Using Robotic Systems

Knee Osteoarthritis

Russian Federation
Federal State Budgetary Organization, Federal Center...

Completed

AESCULAP® Plasmafit® Cementless Acetabular System With Vitelene® Vitamin E Stabilized Highly Crosslinked Polyethylene

Osteoarthritis, Hip | Degenerative Osteoarthritis | Rheumatic Arthritis

Russian Federation
Pfizer

Terminated

Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate (SERUM)

Rheumatoid Arthritis

Spain, Australia, Belgium, France, Hong Kong, Israel, Russian Federation
I.M. Sechenov First Moscow State Medical University

Active, not recruiting

Total Knee Arthroplasty Using an Active Robotic System

Knee Osteoarthritis

Russian Federation
Vertex Pharmaceuticals Incorporated

Completed

A Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702

Rheumatoid Arthritis

Bulgaria, Croatia, Former Serbia and Montenegro, Poland, Russian Federation, Slovenia
I.M. Sechenov First Moscow State Medical University

Recruiting

Personalized Approach to Robotic Total Knee Arthroplasty

Knee Osteoarthritis

Russian Federation
Chong Kun Dang Pharmaceutical

Completed

A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate

Rheumatoid Arthritis

Czechia, Georgia, Poland, Russian Federation, Ukraine
Biocad

Completed

Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis

Rheumatoid Arthritis

India, Russian Federation, Belarus
Biocad

Completed

Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis (BIORA)

Rheumatoid Arthritis

India, Russian Federation, Belarus, Ukraine
Hoffmann-La Roche

Completed

A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.

Rheumatoid Arthritis

Russian Federation
Federal State Budgetary Scientific Institution,...

Not yet recruiting

Diphenhydramine Ointment for Knee Osteoarthritis

Osteoarthritis

Russian Federation
Central Clinical Hospital w/Outpatient Health Center...
Orenburg Regional Clinical Blood Donor Center

Unknown

Autologous Stromal Vascular Fraction of Cells for Treatment of Knee Articular Cartilage Dystrophy

Knee Osteoarthritis

Russian Federation
UCB Pharma

Terminated

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)

Rheumatoid Arthritis | Crohn's Disease

Russian Federation
Novartis Pharmaceuticals

Completed

A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients

Rheumatoid Arthritis

Germany, United States, Belgium, Russian Federation, United Kingdom

Clinical Trials on Adult Onset Rheumatoid Arthritis in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations